Patents by Inventor Teppei Ogata

Teppei Ogata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endogeneous repair factor production accelerators
    Patent number: 8642630
    Abstract: It relates to an endogenous repair factor production accelerator which comprises one or at least two selected from prostaglandin (PG) I2 agonist, EP2 agonist and EP4 agonist. Since prostaglandin (PG) I2 agonist, EP2 agonist or EP4 agonist has various endogenous repair factor production accelerating action, angiogenesis acceleration action and stem cell differentiation induction action, it is useful as preventive and/or therapeutic agents for ischemic organ diseases (e.g., arteriosclerosis obliterans, Buerger disease, Raynaud disease, myocardial infarction, angina pectoris, diabetic neuropathy, spinal canal stenosis, cerebrovascular accidents, cerebral infarction, pulmonary hypertension, bone fracture, Alzheimer disease, etc.) and various cell and organ diseases.
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: February 4, 2014
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Yoshiki Sakai, Akio Nishiura, Teppei Ogata
  • Endogeneous repair factor production promoters
    Patent number: 8436026
    Abstract: It relates to an endogenous repair factor production accelerator which comprises one or at least two selected from prostaglandin (PG) 12 agonist, EP2 agonist and EP4 agonist. Since prostaglandin (PG) 12 agonist, EP2 agonist or EP4 agonist has various endogenous repair factor production accelerating action, angiogenesis acceleration action and stem cell differentiation induction action, it is useful as preventive and/or therapeutic agents for ischemic organ diseases (e.g., arteriosclerosis obliterans, Buerger disease, Raynaud disease, myocardial infarction, angina pectoris, diabetic neuropathy, spinal canal stenosis, cerebrovascular accidents, cerebral infarction, pulmonary hypertension, bone fracture, Alzheimer disease, etc.) and various cell and organ diseases.
    Type: Grant
    Filed: February 20, 2008
    Date of Patent: May 7, 2013
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Yoshiki Sakai, Akio Nishiura, Teppei Ogata
  • Endogenous repair factor production accelerator
    Patent number: 7547715
    Abstract: It relates to an endogenous repair factor production accelerator which comprises one or at least two selected from prostaglandin (PG) I2 agonist, EP2 agonist and EP4 agonist. Since prostaglandin (PG) I2 agonist, EP2 agonist or EP4 agonist has various endogenous repair factor production accelerating action, angiogenesis acceleration action and stem cell differentiation induction action, it is useful as preventive and/or therapeutic agents for ischemic organ diseases (e.g., arteriosclerosis obliterans, Buerger disease, Raynaud disease, myocardial infarction, angina pectoris, diabetic neuropathy, spinal canal stenosis, cerebrovascular accidents, cerebral infarction, pulmonary hypertension, bone fracture, Alzheimer disease, etc.) and various cell and organ diseases.
    Type: Grant
    Filed: October 9, 2003
    Date of Patent: June 16, 2009
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Yoshiki Sakai, Akio Nishiura, Teppei Ogata
  • ENDOGENEOUS REPAIR FACTOR PRODUCTION PROMOTERS
    Publication number: 20080299089
    Abstract: It relates to an endogenous repair factor production accelerator which comprises one or at least two selected from prostaglandin (PG) 12 agonist, EP2 agonist and EP4 agonist. Since prostaglandin (PG) 12 agonist, EP2 agonist or EP4 agonist has various endogenous repair factor production accelerating action, angiogenesis acceleration action and stem cell differentiation induction action, it is useful as preventive and/or therapeutic agents for ischemic organ diseases (e.g., arteriosclerosis obliterans, Buerger disease, Raynaud disease, myocardial infarction, angina pectoris, diabetic neuropathy, spinal canal stenosis, cerebrovascular accidents, cerebral infarction, pulmonary hypertension, bone fracture, Alzheimer disease, etc.) and various cell and organ diseases.
    Type: Application
    Filed: February 20, 2008
    Publication date: December 4, 2008
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshiki SAKAI, Akio Nishiura, Teppei Ogata
  • Endogenous repair factor production promoters
    Publication number: 20060069018
    Abstract: It relates to an endogenous repair factor production accelerator which comprises one or at least two selected from prostaglandin (PG) I2 agonist, EP2 agonist and EP4 agonist. Since prostaglandin (PG) I2 agonist, EP2 agonist or EP4 agonist has various endogenous repair factor production accelerating action, angiogenesis acceleration action and stem cell differentiation induction action, it is useful as preventive and/or therapeutic agents for ischemic organ diseases (e.g., arteriosclerosis obliterans, Buerger disease, Raynaud disease, myocardial infarction, angina pectoris, diabetic neuropathy, spinal canal stenosis, cerebrovascular accidents, cerebral infarction, pulmonary hypertension, bone fracture, Alzheimer disease, etc.) and various cell and organ diseases.
    Type: Application
    Filed: October 9, 2003
    Publication date: March 30, 2006
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshiki Sakai, Akio Nishiura, Teppei Ogata